eanpages
  • General interest
    • All Executive Page Paper of the Month EAN News EAN Congress news COVID-19 Interviews
      EAN Congress news

      Join us for the movement disorders programme at EAN 2022

      May 25, 2022

      EAN Congress news

      EMEAC-IFCN to hold several joint sessions on Clinical Neurophysiology at EAN 2022

      May 25, 2022

      Interviews

      Interview: Wolfgang Grisold, President of the World Federation of Neurology

      May 23, 2022

      EAN Congress news

      EAN Tournament Finals – Neurologists in training, on stage!

      May 20, 2022

      Executive Page Dear EAN members, dear friends, It is my pleasure to give you an update on behalf of the EAN Scientific Committee following a busy year since my appointment as chair. It has been a privilege to be so deeply involved in the scientific activities of the EAN and to work closely with an amazing community of people who are so dedicated to the advancement of neurology. One of the strongest threads within that community is the EAN’s group of Scientific Panels, which are often referred to as the organisation’s ‘scientific backbone’. The panels have a hand in everything the EAN does from a scientific point of view, including coordinating clinical research, disseminating good practice, assisting in planning the EAN annual congress, supporting the EAN’s educational efforts, and producing guidelines that assist neurologists in daily practice. All of this work requires a considerable amount of oversight, and this is why each panel is run by its own Management Group, elected by the panel members. Being a part of one of these Management Groups (PDF) is an opportunity to play a direct part in determining the direction of scientific progress within Europe, and I am excited to say that the call for applications to stand for election will be announced in September. All panel members and EAN individual members are eligible to apply to be candidates, with the vote being held among the existing panel members in autumn. I would like to urge every neurologist with a passion for the scientific future of their special area of interest to consider standing for election to the relevant Management Group and to look out for the call for applications later this month. I can tell you from personal experience that fulfilling a role such as this within the structure of the EAN is a fascinating and extremely rewarding experience. The chance to take on such a unique leadership position should not be missed! The most satisfying aspect of being involved in the EAN’s organisational structure is surely seeing all the hard work and planning come to fruition when a small idea evolves into a newly launched project. One such example is the 1st EAN Science School, taking place in Salzburg next March. The idea of the Science School is to offer early career neurologists with an interest in translational research a new avenue for learning about basic pathomechanisms of neurological disorders. Application for this very first edition, on ‘Pathophysiology of disorders of the nervous system’, closed last week and we have been delighted with the level of interest. It was a pleasure to be part of the task force in charge of planning this new project and I look forward to seeing it officially transferred to the hands of the Scientific Committee after a successful event and evaluation in spring. Of our ongoing activities, one of the most significant is the EAN Neuro-covid Registry, which aims to collate epidemiological data on neurological manifestations in patients with COVID-19 infection reported by neurologists in outpatient services, emergency rooms, and hospital departments. We currently have 1,542 patients entered in the database, from 35 centres across 23 countries. So far, 29 patients have been followed for 12 months and 387 have completed the 6-months follow up. This is a decent start, but I would like to strongly encourage EAN members and their institutions to get involved and contribute cases to what will become an invaluable resource for neurologists and clinicians to improve care for Covid-19 patients. Finally, I would like share a word on a forthcoming collaboration between EAN and the Human Brain Project in December, that I think will interest a lot of EAN members. The EAN-EBRAINS joint workshop on ‘The future of medical data sharing in clinical neurosciences’ will be a three-day virtual event that aims to discuss issues and challenges associated with data sharing in Europe, from ethics to data safety and privacy, including those specific to data federation, such as the development and validation of federated algorithms. The whole workshop is completely free of charge and registration is open until 25 November, so please check out the details and sign up! I wish you all a healthy and pleasant autumn and I look forward to updating you again. Best wishes Thomas Berger Chair of the EAN Scientific Committee

      Executive Page: Join the EAN Panels and reinforce our scientific backbone! (Plus ENERGY update, and our first Science School)

      May 1, 2022

      Executive Page

      Executive Page: National societies, our key partners on the path to progress

      April 6, 2022

      Executive Page

      EAN Statement in support of Ukraine

      March 18, 2022

      Executive Page

      Executive Page: supporting young neurologists in the European Year of Youth

      February 1, 2022

      Paper of the Month

      Research Paper of the Month: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme

      May 1, 2022

      Paper of the Month

      Covid-19 Paper of the month: Clinical outcomes of COVID-19 infection among patients with Alzheimer’s disease or mild cognitive impairment

      May 1, 2022

      Paper of the Month

      Research Paper of the Month: Clonally expanded B cells in multiple sclerosis bind Epstein–Barr virus EBNA1 and GlialCAM

      April 1, 2022

      Paper of the Month

      Covid-19 Paper of the month: SARS-CoV-2 is associated with changes in brain structure in UK Biobank

      April 1, 2022

      EAN News

      Call for new Chairs for EAN Education Committee and EAN Programme Committee

      May 13, 2022

      EAN News

      EAN Seeks New Officers for Committees & Working Groups

      May 3, 2022

      EAN News

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      EAN News

      TREAT AIE: First European networking conference focusing on Autoimmune Encephalitis

      April 27, 2022

      EAN Congress news

      Join us for the movement disorders programme at EAN 2022

      May 25, 2022

      EAN Congress news

      EMEAC-IFCN to hold several joint sessions on Clinical Neurophysiology at EAN 2022

      May 25, 2022

      EAN Congress news

      EAN Tournament Finals – Neurologists in training, on stage!

      May 20, 2022

      EAN Congress news

      ‘Getting evidence into practice’ – the overarching theme for EAN 2022

      May 3, 2022

      COVID-19

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      COVID-19

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      COVID-19

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      COVID-19

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      Interviews

      Interview: Wolfgang Grisold, President of the World Federation of Neurology

      May 23, 2022

      Interviews

      Interview: Prof. Jean-Philippe Azulay, President of the French Society of Neurology

      April 27, 2022

      Interviews Dear EAN members, dear friends, It is my pleasure to give you an update on behalf of the EAN Scientific Committee following a busy year since my appointment as chair. It has been a privilege to be so deeply involved in the scientific activities of the EAN and to work closely with an amazing community of people who are so dedicated to the advancement of neurology. One of the strongest threads within that community is the EAN’s group of Scientific Panels, which are often referred to as the organisation’s ‘scientific backbone’. The panels have a hand in everything the EAN does from a scientific point of view, including coordinating clinical research, disseminating good practice, assisting in planning the EAN annual congress, supporting the EAN’s educational efforts, and producing guidelines that assist neurologists in daily practice. All of this work requires a considerable amount of oversight, and this is why each panel is run by its own Management Group, elected by the panel members. Being a part of one of these Management Groups (PDF) is an opportunity to play a direct part in determining the direction of scientific progress within Europe, and I am excited to say that the call for applications to stand for election will be announced in September. All panel members and EAN individual members are eligible to apply to be candidates, with the vote being held among the existing panel members in autumn. I would like to urge every neurologist with a passion for the scientific future of their special area of interest to consider standing for election to the relevant Management Group and to look out for the call for applications later this month. I can tell you from personal experience that fulfilling a role such as this within the structure of the EAN is a fascinating and extremely rewarding experience. The chance to take on such a unique leadership position should not be missed! The most satisfying aspect of being involved in the EAN’s organisational structure is surely seeing all the hard work and planning come to fruition when a small idea evolves into a newly launched project. One such example is the 1st EAN Science School, taking place in Salzburg next March. The idea of the Science School is to offer early career neurologists with an interest in translational research a new avenue for learning about basic pathomechanisms of neurological disorders. Application for this very first edition, on ‘Pathophysiology of disorders of the nervous system’, closed last week and we have been delighted with the level of interest. It was a pleasure to be part of the task force in charge of planning this new project and I look forward to seeing it officially transferred to the hands of the Scientific Committee after a successful event and evaluation in spring. Of our ongoing activities, one of the most significant is the EAN Neuro-covid Registry, which aims to collate epidemiological data on neurological manifestations in patients with COVID-19 infection reported by neurologists in outpatient services, emergency rooms, and hospital departments. We currently have 1,542 patients entered in the database, from 35 centres across 23 countries. So far, 29 patients have been followed for 12 months and 387 have completed the 6-months follow up. This is a decent start, but I would like to strongly encourage EAN members and their institutions to get involved and contribute cases to what will become an invaluable resource for neurologists and clinicians to improve care for Covid-19 patients. Finally, I would like share a word on a forthcoming collaboration between EAN and the Human Brain Project in December, that I think will interest a lot of EAN members. The EAN-EBRAINS joint workshop on ‘The future of medical data sharing in clinical neurosciences’ will be a three-day virtual event that aims to discuss issues and challenges associated with data sharing in Europe, from ethics to data safety and privacy, including those specific to data federation, such as the development and validation of federated algorithms. The whole workshop is completely free of charge and registration is open until 25 November, so please check out the details and sign up! I wish you all a healthy and pleasant autumn and I look forward to updating you again. Best wishes Thomas Berger Chair of the EAN Scientific Committee

      Interview: Prof. Thomas Berger, President of the Austrian Society of Neurology

      March 22, 2022

      Interviews

      One hot topic, one expert, three questions: Johann Sellner

      February 7, 2022

  • Academic/Scientific
    • All Breaking news Neurology updates Scientific committee reports Scientific panels reports Eur J Neurol Top 10 Articles Scientific Corner
      Scientific Corner

      Join the EAN Guideline Workshop on 24 June!

      May 13, 2022

      Breaking news

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      Breaking news

      Breaking News – May 2022

      May 2, 2022

      Neurology updates

      Neurology Update: Palliative care

      July 6, 2021

      Neurology updates

      Neurology Update: Clinical Neurophysiology

      June 2, 2021

      Neurology updates Hannover Medical School

      Progressive multifocal leukoencephalopathy – promising therapeutic approach with allogeneic BK virus-specific T cells

      May 17, 2021

      Neurology updates

      Neurology Update: Neuroimmunology

      May 12, 2021

      Scientific committee reports

      Scientific Committee Snapshot: Didier Leys

      April 1, 2020

      Scientific committee reports

      Scientific Committee Snapshot: Rigmor Hojland

      February 26, 2020

      Scientific committee reports

      Scientific Committee Snapshot: Christian Enzinger

      December 1, 2019

      Scientific committee reports

      Scientific Committee Snapshot: Maurizio Leone

      November 1, 2019

      Scientific panels reports

      Coma and DOC Panel Update (May-June): news from the EAN Virtual Congress, personalized pain assessment, NIRS-EEG and machine learning to predict outcomes, prevalence of swallowing disorders and new multimodal predictive algorithms.

      August 11, 2020

      Scientific panels reports

      Statement of the EAN Sleep-Wake-Panel

      June 3, 2020

      Scientific panels reports

      Rare Neurological Diseases in the COVID-19 era: Suggestions for information to patients and caregivers

      May 13, 2020

      Scientific panels reports

      Scentific Panel of the Month: Higher Cortical Functions

      March 2, 2020

      Eur J Neurol

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      Eur J Neurol

      European Journal of Neurology welcomes new associate editors

      December 13, 2021

      Eur J Neurol

      New European guideline and expert statements on the management of narcolepsy in adults and children

      June 30, 2021

      Eur J Neurol

      EAN is proud to announce the 2020 Virtual Master Classes Christmas Special

      November 13, 2020

      Top 10 Articles

      EAN is proud to announce the 2020 Virtual Master Classes Christmas Special

      November 13, 2020

      Top 10 Articles

      EUROPEAN JOURNAL OF NEUROLOGY – TOP 15 ARTICLES 2018

      February 1, 2019

      Top 10 Articles

      Interview with Prof. Patrick Cras – UEMS Section of Neurology (SN)

      February 3, 2018

      Top 10 Articles

      Interview with Mr. Bertrand Daval and Mrs. Nathalie Paulus

      February 3, 2018

      Scientific Corner

      Join the EAN Guideline Workshop on 24 June!

      May 13, 2022

      Scientific Corner

      First EAN Science School proves a hit in Salzburg

      April 1, 2022

      Scientific Corner

      Invitation to the EAN-EBRAINS Joint Workshop on ‘The Future of Medical Data Sharing in Clinical Neurosciences’

      July 2, 2021

      Scientific Corner

      1st EAN Science School, 26-29 March 2022: “Pathophysiology of disorders of the nervous system”

      June 18, 2021

  • Educational
    • All eLearning Student Corner E-Brain Grand Rounds Resident and Research Fellows Fellowship reports Education corner
      Education corner

      EAN Virtual Master Classes – A Series of Success!

      May 25, 2022

      Student Corner

      Students’ Corner: A day in the life of a medical student in your country

      May 20, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      Student Corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      eLearning

      Meet our new eLearning Associate Editors

      August 12, 2021

      eLearning

      Welcoming the new EAN eLearning Editors-in-Chief Prof. Barbara Tettenborn and Prof. Christian Müller

      April 1, 2021

      Student Corner

      Students’ Corner: A day in the life of a medical student in your country

      May 20, 2022

      Student Corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      Student Corner

      ‘Why Neurology?’ student essay competition: win a travel grant for a future EAN Congress!

      March 14, 2022

      Student Corner

      Apply for the Student Teaser Fellowship 2022 by March 31!

      March 10, 2022

      E-Brain

      ebrain May update: new website and podcast series

      May 1, 2021

      E-Brain

      EBRA launches 3rd call for clusters

      May 1, 2020

      E-Brain

      News from ebrain

      February 28, 2020

      E-Brain

      ebrain to host the 2019 Neurology Formative Test Questions, from 15 April to 26 May

      April 1, 2019

      Grand Rounds

      eBrain: virtual case report from Belgium

      October 2, 2017

      Grand Rounds

      Free access to Ebrain for EAN members

      July 1, 2016

      Grand Rounds

      Ebrain granted Royal College of Physicians (UK) CPD/CME accreditation

      July 1, 2016

      Grand Rounds

      ebrain session of the month: neuromuscular junction

      February 1, 2016

      Resident and Research Fellows

      Mentor/mentee pairs matched in second round of EAN Mentorship Programme

      April 25, 2022

      Resident and Research Fellows

      RRFS – National Representatives Network Virtual Meeting

      April 12, 2022

      Resident and Research Fellows

      EAN Autumn School application open until 1 June

      April 1, 2022

      Resident and Research Fellows

      Nicosia, Cyprus, hosts first in-person Regional Teaching Course since start of pandemic

      March 31, 2022

      Fellowship reports

      Clinical Fellowship Reports 2021

      May 9, 2022

      Fellowship reports

      Clinical Fellowship Reports 2021

      April 12, 2022

      Fellowship reports

      Research Fellowship Report 2020

      April 12, 2022

      Fellowship reports

      Research Fellowship Report 2020

      March 21, 2022

      Education corner

      EAN Virtual Master Classes – A Series of Success!

      May 25, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      Education corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      Education corner

      Mentor/mentee pairs matched in second round of EAN Mentorship Programme

      April 25, 2022

  • Other News
    • All EAN Staff Grant opportunities News from EAN member societies EBC EFNA News in general Patients societies reports Surveys Forum
      News in general

      EAN lecture at the International Neuro-Urology Society annual congress 2022

      May 25, 2022

      News in general

      EPA-EAN Joint Symposium: ‘Etiology and Treatment of the Long Covid-19 Syndrome’ and other highlights at the 30th European Congress of Psychiatry

      May 25, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      News from EAN member societies

      Alzheimer Europe publishes new reports on ‘sex, gender and sexuality in the context of dementia’, and ‘dementia-inclusive initiatives and communities’

      April 5, 2022

      EAN Staff

      EAN Head Office Profiles: Julia & Maria

      April 4, 2022

      EAN Staff

      EAN Head Office Profiles: Elisabeth & Magdalena

      January 28, 2022

      EAN Staff

      EAN Head Office Profiles: Lucia & Anja

      January 3, 2022

      EAN Staff

      EAN Head Office Profiles: Florian & Helene

      December 2, 2021

      Grant opportunities

      1st EAN Science School, 26-29 March 2022: “Pathophysiology of disorders of the nervous system”

      June 18, 2021

      Grant opportunities

      European Commission: Innovation and novelty in medical devices and in vitro diagnostic devices; towards common concepts of innovation-related risk assessments

      November 1, 2019

      Grant opportunities

      GBS|CIDP Foundation International 2020 Research Grant Opportunity

      October 29, 2019

      Grant opportunities

      The Clinical Fellowship application deadline is approaching

      October 1, 2019

      News from EAN member societies

      Alzheimer Europe publishes new reports on ‘sex, gender and sexuality in the context of dementia’, and ‘dementia-inclusive initiatives and communities’

      April 5, 2022

      News from EAN member societies

      Look back at scientific highlights of ECTRIMS 2021

      February 9, 2022

      News from EAN member societies

      Austrian Society of Neurology meeting in-person in March 2022

      November 30, 2021

      News from EAN member societies

      Alzheimer Europe co-authors paper on dementia risk communication

      November 29, 2021

      EBC

      Value of Treatment project releases results and calls to action

      March 29, 2022

      EBC

      Best practices for patient safety: An EU-wide view on the use of medicines off-label

      December 31, 2021

      EBC

      Creating synergies and showcasing innovation: Brain Innovation Days 2021

      November 30, 2021

      EBC

      Best practices for patient safety: Register now!

      October 28, 2021

      EFNA

      OneNeurology European Summit underlines urgent need to prioritise neurology and drive change

      December 31, 2021

      EFNA

      EFNA launch eLearning Platform for neurology advocates

      February 1, 2021

      EFNA

      ‘Me and My Brain’ – Art Competition winners announced!

      February 1, 2021

      EFNA

      Survey on the impact of COVID-19 on neurology service delivery

      November 1, 2020

      News in general

      EAN lecture at the International Neuro-Urology Society annual congress 2022

      May 25, 2022

      News in general

      EPA-EAN Joint Symposium: ‘Etiology and Treatment of the Long Covid-19 Syndrome’ and other highlights at the 30th European Congress of Psychiatry

      May 25, 2022

      News in general

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      News in general

      Value of Treatment project releases results and calls to action

      March 29, 2022

      Patients societies reports

      News from Alzheimer Europe

      March 2, 2020

      Patients societies reports

      News from the WHO

      January 9, 2020

      Patients societies reports

      News from EFIC and the European Pain Forum

      January 3, 2020

      Patients societies reports

      News from EFIC and the European Pain Forum

      January 2, 2020

      Surveys

      Survey: management of covert brain infarction

      October 29, 2021

      Surveys

      Driving with an intracranial tumor

      July 13, 2020

      Surveys

      SURVEY: Driving with an intracranial tumor

      June 25, 2020

      Surveys

      EAN SURVEY: Neurological Symptoms in COVID-19 Patients

      April 10, 2020

      Forum

      Call for Applications: e-Learning Platform Editor-in-Chief

      August 4, 2020

      Forum

      Neurological News from Denmark VI – the land of the 2nd EAN congress 2016: Pain Research in Denmark from a neurological perspective

      April 1, 2016

      Forum

      Neurological News from Denmark V – the land of the 2nd EAN congress 2016: Clinical Dementia Research in Denmark

      March 1, 2016

      Forum

      Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri – Comment to EMA recommendation

      March 1, 2016

  • EAN
  • Congress 2022
  • EAN pages
  • Eur J Neurol
  • Virtual Congress

eanpages

  • General interest
    • All Executive Page Paper of the Month EAN News EAN Congress news COVID-19 Interviews
      EAN Congress news

      Join us for the movement disorders programme at EAN 2022

      May 25, 2022

      EAN Congress news

      EMEAC-IFCN to hold several joint sessions on Clinical Neurophysiology at EAN 2022

      May 25, 2022

      Interviews

      Interview: Wolfgang Grisold, President of the World Federation of Neurology

      May 23, 2022

      EAN Congress news

      EAN Tournament Finals – Neurologists in training, on stage!

      May 20, 2022

      Executive Page Dear EAN members, dear friends, It is my pleasure to give you an update on behalf of the EAN Scientific Committee following a busy year since my appointment as chair. It has been a privilege to be so deeply involved in the scientific activities of the EAN and to work closely with an amazing community of people who are so dedicated to the advancement of neurology. One of the strongest threads within that community is the EAN’s group of Scientific Panels, which are often referred to as the organisation’s ‘scientific backbone’. The panels have a hand in everything the EAN does from a scientific point of view, including coordinating clinical research, disseminating good practice, assisting in planning the EAN annual congress, supporting the EAN’s educational efforts, and producing guidelines that assist neurologists in daily practice. All of this work requires a considerable amount of oversight, and this is why each panel is run by its own Management Group, elected by the panel members. Being a part of one of these Management Groups (PDF) is an opportunity to play a direct part in determining the direction of scientific progress within Europe, and I am excited to say that the call for applications to stand for election will be announced in September. All panel members and EAN individual members are eligible to apply to be candidates, with the vote being held among the existing panel members in autumn. I would like to urge every neurologist with a passion for the scientific future of their special area of interest to consider standing for election to the relevant Management Group and to look out for the call for applications later this month. I can tell you from personal experience that fulfilling a role such as this within the structure of the EAN is a fascinating and extremely rewarding experience. The chance to take on such a unique leadership position should not be missed! The most satisfying aspect of being involved in the EAN’s organisational structure is surely seeing all the hard work and planning come to fruition when a small idea evolves into a newly launched project. One such example is the 1st EAN Science School, taking place in Salzburg next March. The idea of the Science School is to offer early career neurologists with an interest in translational research a new avenue for learning about basic pathomechanisms of neurological disorders. Application for this very first edition, on ‘Pathophysiology of disorders of the nervous system’, closed last week and we have been delighted with the level of interest. It was a pleasure to be part of the task force in charge of planning this new project and I look forward to seeing it officially transferred to the hands of the Scientific Committee after a successful event and evaluation in spring. Of our ongoing activities, one of the most significant is the EAN Neuro-covid Registry, which aims to collate epidemiological data on neurological manifestations in patients with COVID-19 infection reported by neurologists in outpatient services, emergency rooms, and hospital departments. We currently have 1,542 patients entered in the database, from 35 centres across 23 countries. So far, 29 patients have been followed for 12 months and 387 have completed the 6-months follow up. This is a decent start, but I would like to strongly encourage EAN members and their institutions to get involved and contribute cases to what will become an invaluable resource for neurologists and clinicians to improve care for Covid-19 patients. Finally, I would like share a word on a forthcoming collaboration between EAN and the Human Brain Project in December, that I think will interest a lot of EAN members. The EAN-EBRAINS joint workshop on ‘The future of medical data sharing in clinical neurosciences’ will be a three-day virtual event that aims to discuss issues and challenges associated with data sharing in Europe, from ethics to data safety and privacy, including those specific to data federation, such as the development and validation of federated algorithms. The whole workshop is completely free of charge and registration is open until 25 November, so please check out the details and sign up! I wish you all a healthy and pleasant autumn and I look forward to updating you again. Best wishes Thomas Berger Chair of the EAN Scientific Committee

      Executive Page: Join the EAN Panels and reinforce our scientific backbone! (Plus ENERGY update, and our first Science School)

      May 1, 2022

      Executive Page

      Executive Page: National societies, our key partners on the path to progress

      April 6, 2022

      Executive Page

      EAN Statement in support of Ukraine

      March 18, 2022

      Executive Page

      Executive Page: supporting young neurologists in the European Year of Youth

      February 1, 2022

      Paper of the Month

      Research Paper of the Month: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme

      May 1, 2022

      Paper of the Month

      Covid-19 Paper of the month: Clinical outcomes of COVID-19 infection among patients with Alzheimer’s disease or mild cognitive impairment

      May 1, 2022

      Paper of the Month

      Research Paper of the Month: Clonally expanded B cells in multiple sclerosis bind Epstein–Barr virus EBNA1 and GlialCAM

      April 1, 2022

      Paper of the Month

      Covid-19 Paper of the month: SARS-CoV-2 is associated with changes in brain structure in UK Biobank

      April 1, 2022

      EAN News

      Call for new Chairs for EAN Education Committee and EAN Programme Committee

      May 13, 2022

      EAN News

      EAN Seeks New Officers for Committees & Working Groups

      May 3, 2022

      EAN News

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      EAN News

      TREAT AIE: First European networking conference focusing on Autoimmune Encephalitis

      April 27, 2022

      EAN Congress news

      Join us for the movement disorders programme at EAN 2022

      May 25, 2022

      EAN Congress news

      EMEAC-IFCN to hold several joint sessions on Clinical Neurophysiology at EAN 2022

      May 25, 2022

      EAN Congress news

      EAN Tournament Finals – Neurologists in training, on stage!

      May 20, 2022

      EAN Congress news

      ‘Getting evidence into practice’ – the overarching theme for EAN 2022

      May 3, 2022

      COVID-19

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      COVID-19

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      COVID-19

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      COVID-19

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      Interviews

      Interview: Wolfgang Grisold, President of the World Federation of Neurology

      May 23, 2022

      Interviews

      Interview: Prof. Jean-Philippe Azulay, President of the French Society of Neurology

      April 27, 2022

      Interviews Dear EAN members, dear friends, It is my pleasure to give you an update on behalf of the EAN Scientific Committee following a busy year since my appointment as chair. It has been a privilege to be so deeply involved in the scientific activities of the EAN and to work closely with an amazing community of people who are so dedicated to the advancement of neurology. One of the strongest threads within that community is the EAN’s group of Scientific Panels, which are often referred to as the organisation’s ‘scientific backbone’. The panels have a hand in everything the EAN does from a scientific point of view, including coordinating clinical research, disseminating good practice, assisting in planning the EAN annual congress, supporting the EAN’s educational efforts, and producing guidelines that assist neurologists in daily practice. All of this work requires a considerable amount of oversight, and this is why each panel is run by its own Management Group, elected by the panel members. Being a part of one of these Management Groups (PDF) is an opportunity to play a direct part in determining the direction of scientific progress within Europe, and I am excited to say that the call for applications to stand for election will be announced in September. All panel members and EAN individual members are eligible to apply to be candidates, with the vote being held among the existing panel members in autumn. I would like to urge every neurologist with a passion for the scientific future of their special area of interest to consider standing for election to the relevant Management Group and to look out for the call for applications later this month. I can tell you from personal experience that fulfilling a role such as this within the structure of the EAN is a fascinating and extremely rewarding experience. The chance to take on such a unique leadership position should not be missed! The most satisfying aspect of being involved in the EAN’s organisational structure is surely seeing all the hard work and planning come to fruition when a small idea evolves into a newly launched project. One such example is the 1st EAN Science School, taking place in Salzburg next March. The idea of the Science School is to offer early career neurologists with an interest in translational research a new avenue for learning about basic pathomechanisms of neurological disorders. Application for this very first edition, on ‘Pathophysiology of disorders of the nervous system’, closed last week and we have been delighted with the level of interest. It was a pleasure to be part of the task force in charge of planning this new project and I look forward to seeing it officially transferred to the hands of the Scientific Committee after a successful event and evaluation in spring. Of our ongoing activities, one of the most significant is the EAN Neuro-covid Registry, which aims to collate epidemiological data on neurological manifestations in patients with COVID-19 infection reported by neurologists in outpatient services, emergency rooms, and hospital departments. We currently have 1,542 patients entered in the database, from 35 centres across 23 countries. So far, 29 patients have been followed for 12 months and 387 have completed the 6-months follow up. This is a decent start, but I would like to strongly encourage EAN members and their institutions to get involved and contribute cases to what will become an invaluable resource for neurologists and clinicians to improve care for Covid-19 patients. Finally, I would like share a word on a forthcoming collaboration between EAN and the Human Brain Project in December, that I think will interest a lot of EAN members. The EAN-EBRAINS joint workshop on ‘The future of medical data sharing in clinical neurosciences’ will be a three-day virtual event that aims to discuss issues and challenges associated with data sharing in Europe, from ethics to data safety and privacy, including those specific to data federation, such as the development and validation of federated algorithms. The whole workshop is completely free of charge and registration is open until 25 November, so please check out the details and sign up! I wish you all a healthy and pleasant autumn and I look forward to updating you again. Best wishes Thomas Berger Chair of the EAN Scientific Committee

      Interview: Prof. Thomas Berger, President of the Austrian Society of Neurology

      March 22, 2022

      Interviews

      One hot topic, one expert, three questions: Johann Sellner

      February 7, 2022

  • Academic/Scientific
    • All Breaking news Neurology updates Scientific committee reports Scientific panels reports Eur J Neurol Top 10 Articles Scientific Corner
      Scientific Corner

      Join the EAN Guideline Workshop on 24 June!

      May 13, 2022

      Breaking news

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Cross-Sectional Case Control Studies – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022

      May 4, 2022

      Breaking news

      COVID-19 Breaking News: Meta-analyses/systematic reviews – May 2022

      May 4, 2022

      Breaking news

      Breaking News – May 2022

      May 2, 2022

      Neurology updates

      Neurology Update: Palliative care

      July 6, 2021

      Neurology updates

      Neurology Update: Clinical Neurophysiology

      June 2, 2021

      Neurology updates Hannover Medical School

      Progressive multifocal leukoencephalopathy – promising therapeutic approach with allogeneic BK virus-specific T cells

      May 17, 2021

      Neurology updates

      Neurology Update: Neuroimmunology

      May 12, 2021

      Scientific committee reports

      Scientific Committee Snapshot: Didier Leys

      April 1, 2020

      Scientific committee reports

      Scientific Committee Snapshot: Rigmor Hojland

      February 26, 2020

      Scientific committee reports

      Scientific Committee Snapshot: Christian Enzinger

      December 1, 2019

      Scientific committee reports

      Scientific Committee Snapshot: Maurizio Leone

      November 1, 2019

      Scientific panels reports

      Coma and DOC Panel Update (May-June): news from the EAN Virtual Congress, personalized pain assessment, NIRS-EEG and machine learning to predict outcomes, prevalence of swallowing disorders and new multimodal predictive algorithms.

      August 11, 2020

      Scientific panels reports

      Statement of the EAN Sleep-Wake-Panel

      June 3, 2020

      Scientific panels reports

      Rare Neurological Diseases in the COVID-19 era: Suggestions for information to patients and caregivers

      May 13, 2020

      Scientific panels reports

      Scentific Panel of the Month: Higher Cortical Functions

      March 2, 2020

      Eur J Neurol

      EAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders

      May 2, 2022

      Eur J Neurol

      European Journal of Neurology welcomes new associate editors

      December 13, 2021

      Eur J Neurol

      New European guideline and expert statements on the management of narcolepsy in adults and children

      June 30, 2021

      Eur J Neurol

      EAN is proud to announce the 2020 Virtual Master Classes Christmas Special

      November 13, 2020

      Top 10 Articles

      EAN is proud to announce the 2020 Virtual Master Classes Christmas Special

      November 13, 2020

      Top 10 Articles

      EUROPEAN JOURNAL OF NEUROLOGY – TOP 15 ARTICLES 2018

      February 1, 2019

      Top 10 Articles

      Interview with Prof. Patrick Cras – UEMS Section of Neurology (SN)

      February 3, 2018

      Top 10 Articles

      Interview with Mr. Bertrand Daval and Mrs. Nathalie Paulus

      February 3, 2018

      Scientific Corner

      Join the EAN Guideline Workshop on 24 June!

      May 13, 2022

      Scientific Corner

      First EAN Science School proves a hit in Salzburg

      April 1, 2022

      Scientific Corner

      Invitation to the EAN-EBRAINS Joint Workshop on ‘The Future of Medical Data Sharing in Clinical Neurosciences’

      July 2, 2021

      Scientific Corner

      1st EAN Science School, 26-29 March 2022: “Pathophysiology of disorders of the nervous system”

      June 18, 2021

  • Educational
    • All eLearning Student Corner E-Brain Grand Rounds Resident and Research Fellows Fellowship reports Education corner
      Education corner

      EAN Virtual Master Classes – A Series of Success!

      May 25, 2022

      Student Corner

      Students’ Corner: A day in the life of a medical student in your country

      May 20, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      Student Corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      eLearning

      Meet our new eLearning Associate Editors

      August 12, 2021

      eLearning

      Welcoming the new EAN eLearning Editors-in-Chief Prof. Barbara Tettenborn and Prof. Christian Müller

      April 1, 2021

      Student Corner

      Students’ Corner: A day in the life of a medical student in your country

      May 20, 2022

      Student Corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      Student Corner

      ‘Why Neurology?’ student essay competition: win a travel grant for a future EAN Congress!

      March 14, 2022

      Student Corner

      Apply for the Student Teaser Fellowship 2022 by March 31!

      March 10, 2022

      E-Brain

      ebrain May update: new website and podcast series

      May 1, 2021

      E-Brain

      EBRA launches 3rd call for clusters

      May 1, 2020

      E-Brain

      News from ebrain

      February 28, 2020

      E-Brain

      ebrain to host the 2019 Neurology Formative Test Questions, from 15 April to 26 May

      April 1, 2019

      Grand Rounds

      eBrain: virtual case report from Belgium

      October 2, 2017

      Grand Rounds

      Free access to Ebrain for EAN members

      July 1, 2016

      Grand Rounds

      Ebrain granted Royal College of Physicians (UK) CPD/CME accreditation

      July 1, 2016

      Grand Rounds

      ebrain session of the month: neuromuscular junction

      February 1, 2016

      Resident and Research Fellows

      Mentor/mentee pairs matched in second round of EAN Mentorship Programme

      April 25, 2022

      Resident and Research Fellows

      RRFS – National Representatives Network Virtual Meeting

      April 12, 2022

      Resident and Research Fellows

      EAN Autumn School application open until 1 June

      April 1, 2022

      Resident and Research Fellows

      Nicosia, Cyprus, hosts first in-person Regional Teaching Course since start of pandemic

      March 31, 2022

      Fellowship reports

      Clinical Fellowship Reports 2021

      May 9, 2022

      Fellowship reports

      Clinical Fellowship Reports 2021

      April 12, 2022

      Fellowship reports

      Research Fellowship Report 2020

      April 12, 2022

      Fellowship reports

      Research Fellowship Report 2020

      March 21, 2022

      Education corner

      EAN Virtual Master Classes – A Series of Success!

      May 25, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      Education corner

      Student Teaser Fellowship winners 2022

      May 11, 2022

      Education corner

      Mentor/mentee pairs matched in second round of EAN Mentorship Programme

      April 25, 2022

  • Other News
    • All EAN Staff Grant opportunities News from EAN member societies EBC EFNA News in general Patients societies reports Surveys Forum
      News in general

      EAN lecture at the International Neuro-Urology Society annual congress 2022

      May 25, 2022

      News in general

      EPA-EAN Joint Symposium: ‘Etiology and Treatment of the Long Covid-19 Syndrome’ and other highlights at the 30th European Congress of Psychiatry

      May 25, 2022

      Education corner

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      News from EAN member societies

      Alzheimer Europe publishes new reports on ‘sex, gender and sexuality in the context of dementia’, and ‘dementia-inclusive initiatives and communities’

      April 5, 2022

      EAN Staff

      EAN Head Office Profiles: Julia & Maria

      April 4, 2022

      EAN Staff

      EAN Head Office Profiles: Elisabeth & Magdalena

      January 28, 2022

      EAN Staff

      EAN Head Office Profiles: Lucia & Anja

      January 3, 2022

      EAN Staff

      EAN Head Office Profiles: Florian & Helene

      December 2, 2021

      Grant opportunities

      1st EAN Science School, 26-29 March 2022: “Pathophysiology of disorders of the nervous system”

      June 18, 2021

      Grant opportunities

      European Commission: Innovation and novelty in medical devices and in vitro diagnostic devices; towards common concepts of innovation-related risk assessments

      November 1, 2019

      Grant opportunities

      GBS|CIDP Foundation International 2020 Research Grant Opportunity

      October 29, 2019

      Grant opportunities

      The Clinical Fellowship application deadline is approaching

      October 1, 2019

      News from EAN member societies

      Alzheimer Europe publishes new reports on ‘sex, gender and sexuality in the context of dementia’, and ‘dementia-inclusive initiatives and communities’

      April 5, 2022

      News from EAN member societies

      Look back at scientific highlights of ECTRIMS 2021

      February 9, 2022

      News from EAN member societies

      Austrian Society of Neurology meeting in-person in March 2022

      November 30, 2021

      News from EAN member societies

      Alzheimer Europe co-authors paper on dementia risk communication

      November 29, 2021

      EBC

      Value of Treatment project releases results and calls to action

      March 29, 2022

      EBC

      Best practices for patient safety: An EU-wide view on the use of medicines off-label

      December 31, 2021

      EBC

      Creating synergies and showcasing innovation: Brain Innovation Days 2021

      November 30, 2021

      EBC

      Best practices for patient safety: Register now!

      October 28, 2021

      EFNA

      OneNeurology European Summit underlines urgent need to prioritise neurology and drive change

      December 31, 2021

      EFNA

      EFNA launch eLearning Platform for neurology advocates

      February 1, 2021

      EFNA

      ‘Me and My Brain’ – Art Competition winners announced!

      February 1, 2021

      EFNA

      Survey on the impact of COVID-19 on neurology service delivery

      November 1, 2020

      News in general

      EAN lecture at the International Neuro-Urology Society annual congress 2022

      May 25, 2022

      News in general

      EPA-EAN Joint Symposium: ‘Etiology and Treatment of the Long Covid-19 Syndrome’ and other highlights at the 30th European Congress of Psychiatry

      May 25, 2022

      News in general

      Organise an EAN-Day or EAN Regional Teaching Course in your Country!

      May 17, 2022

      News in general

      Value of Treatment project releases results and calls to action

      March 29, 2022

      Patients societies reports

      News from Alzheimer Europe

      March 2, 2020

      Patients societies reports

      News from the WHO

      January 9, 2020

      Patients societies reports

      News from EFIC and the European Pain Forum

      January 3, 2020

      Patients societies reports

      News from EFIC and the European Pain Forum

      January 2, 2020

      Surveys

      Survey: management of covert brain infarction

      October 29, 2021

      Surveys

      Driving with an intracranial tumor

      July 13, 2020

      Surveys

      SURVEY: Driving with an intracranial tumor

      June 25, 2020

      Surveys

      EAN SURVEY: Neurological Symptoms in COVID-19 Patients

      April 10, 2020

      Forum

      Call for Applications: e-Learning Platform Editor-in-Chief

      August 4, 2020

      Forum

      Neurological News from Denmark VI – the land of the 2nd EAN congress 2016: Pain Research in Denmark from a neurological perspective

      April 1, 2016

      Forum

      Neurological News from Denmark V – the land of the 2nd EAN congress 2016: Clinical Dementia Research in Denmark

      March 1, 2016

      Forum

      Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri – Comment to EMA recommendation

      March 1, 2016

General interestCOVID-19Top Articles

Immunotherapy for patients with neuroimmunological disorders during the COVID-19 pandemic

April 1, 2020

24. March 2020

Corona Virus Disease 2019 (COVID-19) is a new illness caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which typically causes fever, cough, respiratory symptoms, diarrhea, reduction of smell and taste sensation and may lead to pneumonia, acute respiratory distress syndrome and in some patients, death. Nearly every country in the world has been affected with this virus and is currently defined as a pandemic by the World Health Organization. There are no known proven therapies for this virus at present.

There is currently no evidence on how COVID-19 affects people with neuroimmunological disorders (including Multiple sclerosis, CNS Vasculitis, Myasthenia gravis, Immune neuropathies, Myositis or autoimmune encephalitis). However, most patients with neuroimmunological disordes are on immunosuppressive or immunomodulatory therapies. Some diseases, especially myasthenia gravis, also causes respiratory muscle weakness, and there is heightened sense of concern for potential risk of infections with this novel coronavirus and the severity of manifestations.

Individuals with neuroimmunological disorders have asked for guidance on the use of therapies during the COVID-19 pandemic. There are now numerous recommendations circulating, especially by national and international societies for distinct diseases, that attempt to provide clarity and guidance. There are differences among the recommendations that have created confusion and immunotherapy decision making varies significantly from country to country, ranging from highly provider-directed to a more collaborative decision-making model.

EAN here provides some general recommendations regarding major questions related to immune therapy and neuroimmunological diseases.

The EAN expert panel* believes that therapy decisions should be individualized and made collaboratively between the person with the disease and his/her healthcare provider.

In general: should immune therapies in patients with neuroimmunological disorders be reduced or stopped?

Immune therapies include IVIG, Corticosteroids, Alemtuzumab, Ocrelizumab, Rituximab, Interferon-beta, Glatiramer acetate, Prednisolon, Dimethylfumarate, Teriflunomide, Fingolimod, Cladribine, Azathioprine, Mycophenolate Mofetil, Cyclosporin A, Methotrexate, Eculizumab, Tocilizumab.

Currently it is unclear whether and how immune therapy per se does increase the risk of SARSCoV-2 infection. Immuntherapy belongs in most of the cases to the standard of care for immune-mediated neurological disorders, and cessation can cause disease exacerbation. This risk can be higher than the risk to worsen COVID-19 disease course under current immune therapy.

It is recommended that patients on immunosuppressive medications should practice extravigilant social distancing, including avoiding public gatherings/crowds, avoiding crowded public transport and where possible use alternatives to face-to-face consultations (eg: telemedicine). Moreover, good personal hygiene is extremely important, it is recommended to wash oneself hands frequently. If travelling or using public transport is absolutely necessary, it is recommended the use of protective masks and hand sanitizing

Are there specific recommendations for certain types of immune therapies?

Some of the treatments are applied non-continuously, and short-term changes of the regimen might not be reasonable.

Certain infusion therapies (e.g., natalizumab, rituximab, ocrelizumab, alemtuzumab) may require travel to infusion centers and we strongly recommend that this decision be made based on regional incidence of COVID-19 and risk/benefit of the therapy for the individual patient. Your healthcare provider should be able to give you region-specific advice, and where possible consider switching to home infusion.

Sphingosin-1-Phosphat-Receptor-Modulators (Fingolimod, Siponimod) in general are associated with increased risk of respiratory infections, but cessation of therapy is associated with significant risk of disease activity return in MS patients (including rebound activity). Patients should be specifically advised to confine contacts and minimize risks of infection.

Especially for therapies with immune depleting properties or primary immune suppressive agents (especially Ocrelizumab, Rituximab, Cladribine, Alemtuzumab, Mitoxantrone), in the first weeks after their initiation there could be an increased risk of infections. In older patients and patients with comorbidity (cardiovascular, pulmonary), treatment initiation should be delayed (if disease activity allows). For patients with ongoing therapies, timing of retreatment with immune depleting therapies should be revised by consultant and delay in treatment is recommended if possible or consider alternative options.

Intravenous corticosteroid pulse therapies that are provided in the absence of a clear clinical indication or justification should be avoided.

There is currently no evidence to suggest that intravenous immunoglobulin (IVIG) or plasma exchange (Plex) carry any additional risk in catching COVID-19. However, the use of IVIG has to be based on individual patient need and indiscriminate use should be avoided. In general, Plex and IVIG should be reserved for patients with acute exacerbations. However, the panel recognize that there are some patients receiving these as maintenance therapy, who should continue these, but extra precautions may need to be taken because of the need for travel to and from a healthcare facility.

There is currently no evidence to support the assumption that inhibition of complement using mAb eculizumab increases susceptibility to COVID infection or its outcome.

There is currently no evidence to support the assumption that inhibition of leucocyte traffick with natalizumab increases susceptibility to COVID infection or its outcome.

Some of the immune therapies require frequent blood work monitoring and decision regarding ongoing need for testing which requires patient to leave their home should be individualized and based on regional COVID-19 incidence.

In any case of acute signs of infection, immune therapies must not be initiated or continued, especially immune depleting agents should be delayed until symptoms have disappeared.

What to consider when starting an immune therapy in patients now:

Start of immune depleting therapies

Before starting a cell depleting therapy (e.g., ocrelizumab, rituximab, alemtuzumab, cladribine) healthcare providers should consider the risk of immune suppression and susceptibility to infections up to several weeks after treatment initiation. It may be advisable to delay initiation of cell depleting therapies, until the peak of the pandemic is over in the region. However, in occasional patients the risk of not starting the cell depleting therapy may outweigh the risk of severe COVID-19 infection and this has to be discussed with the patient in detail. Also the potential of “bridging therapy” concepts has to be discussed with the patient in detail.

How to deal with patients in ongoing clinical trials?

Currently, there are numerous ongoing clinical trials in several neuroimmunological diseases and we strongly recommend that any decision regarding ongoing need for in-person evaluations and treatments under the clinical trial be based with consideration for patients’ best interest. In clinical trials also the sponsors responsibility and communication regarding study protocol continuations has to be considered.

Is there reasonable evidence for medications treating COVID 19?

Various medications have been mentioned in the news and social media as being useful to treat COVID-19 (e.g.,chloroquin, azithromycin, anti-virals, etc). However, these are not proven to be effective at this time. Patients should be aware that some of these medications can potentially worsen MG and should avoid using these without specific medical approval. Whether anti-Il-& receptor mAb (tocilizumab, sartralizumab), natalizumab or eculizumab are useful as treatments of COVID-19 pneumonia is currently unclear. Several clinical trial are now underway to explore the potential of distinct modes of action in this serious condition (for further informations see clinicaltrials.gov).

Should neuroimmunological patients go for vaccinations?

Vaccinations can protect for a variety of infections/pathogens. However, in the current situation it is recommended to only use dead vaccines in this patient group. For the actual corona virus there is no vaccine available.

We are continuing to monitor this quickly evolving situation and these recommendations may be modified as data becomes available.

* EAN expert panel:

Massimo Filippi, MD, FEAN
Co-Chair – EAN SP Multiple Sclerosis
Full Professor of Neurology Chair,
Neurology Unit Director,
MS Center Vita-Salute
San Raffaele University and San Raffaele Scientific Institute Milan,
Italy

Sonja Hochmeister M.D. Ph.D.
Co – chair EAN SP Neuroimmunology
Associate Professor of Neurology Medical University Graz
Dept. of Neurology
Graz, Austria

Celia Oreja-Guevara
Co – chair EAN SP Multiple Sclerosis
Head of MS Center
Vice Chair of Neurology Hospital Clinico San Carlos
Associate Professor of Neurology
Madrid, Spain

Radu Tanasescu MD, PhD
Co-Chair – EAN SP Neuroimmunology
Honorary Associate Professor of Neurology University of Nottingham, Nottingham, UK
Associate Professor of Neurology
University Carol Davila Bucharest, Romania

Heinz Wiendl, MD (FEAN, FAAN)
Member of EAN SP Multiple Sclerosis
Professor of Neurology and Chair,
Prof. h.c. Department of Neurology With Institute of Translational Neurology University of Münster
Münster , Germany

Immunotherapy for patients with neuroimmunological disorders during the COVID-19 pandemic was last modified: April 17th, 2020 by Editor
Share this...
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
previous post
EAN / EANM Memorandum of Understanding signed
next post
SPECIAL REPORT COVID-19: Neurologists adapt in Northern Italy

You may also like

20.12. Gingerbread cookies

December 20, 2018

Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19

July 1, 2021

Run4Brain Initiative

September 1, 2018

SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

May 5, 2021

Breaking News: Updated restrictions for Gilenya – multiple sclerosis medicine not to be used in pregnancy

August 23, 2019

Interview with Prof. Jesus Lafuente, President of EANS

February 1, 2019

Oslo 2019: Which session you should not miss…

May 1, 2019

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review

July 1, 2021

Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike

July 29, 2021

Amsterdam 2017 – The Educational Sessions – Interactive sessions

April 1, 2017

Leave a Comment Cancel Reply

You need to be logged in to comment. Please login to MyEAN on top.

EANcore COVID-19

Upcoming Events

May
31
Tue
2:00 pm European Brain Health Summit (On...
European Brain Health Summit (On...
May 31 @ 2:00 pm – 5:15 pm
The European Academy of Neurology (EAN) Brain Health Strategy will greatly contribute to the resilience of Europe’s Healthcare system by not only reducing the burden of chronic neurological disorders, such…
Jun
4
Sat
all-day 30th European Congress of Psychi...
30th European Congress of Psychi...
Jun 4 – Jun 7 all-day
The 30th European Congress of Psychiatry, organised by the largest association of psychiatrists in Europe, will take place on 4-7 June 2022 in Budapest, Hungary. Make sure to participate in…
Jun
9
Thu
all-day EAN National Society Forum
EAN National Society Forum
Jun 9 all-day
 Share this...FacebookTwitterLinkedin
all-day INUS Annual Congress (Internatio...
INUS Annual Congress (Internatio...
Jun 9 – Jun 11 all-day
The INUS annual congress takes place on 9-11 June in Innsbruck, Austria. Make sure to listen to the EAN Lecture by Prof. Mario Habek on “Urogenital and other autonomic manifestations…
Jun
25
Sat
all-day 8th Congress of the European Aca... @ Austria Center Vienna (and online!)
8th Congress of the European Aca... @ Austria Center Vienna (and online!)
Jun 25 – Jun 28 all-day
We are delighted to welcome you back to the historic city of Vienna for the 8th Congress of the European Academy of Neurology (EAN), on June 25-28, 2022! The 8th…
View Calendar

Latest Tweets

  • Tweet Avatar
    EANeurology
    @EANeurology
    Ten #neurologists in training will attempt to win over the judges during our exciting EAN Tournament Finals at… https://t.co/3sgBSIXdQZ

    18 hours ago
  • Tweet Avatar
    EANeurology
    @EANeurology
    Only 1 week left for EAN RRFS members to apply for our Autumn School in Loutraki, Greece, on October 20-24! All det… https://t.co/HTMBP7A3ts

    2 days ago
  • Tweet Avatar
    EANeurology
    @EANeurology
    RT @OneNeurology_: Dévora Kestel, Director, Mental Health and Substance Use Department, World Health Organization, speaking at our… https://t.co/lG3YVfMLIc

    3 days ago
  • Tweet Avatar
    EANeurology
    @EANeurology
    RT @BrusselsDC: I had a Dream: that #Neurology and #PublicHealth work together. #GlobalActionPlan is giving us #hope but also the… https://t.co/lnrQydGVvL

    3 days ago
  • Tweet Avatar
    EANeurology
    @EANeurology
    RT @BrusselsDC: « Today’s achievement brings #HOPE for people living w.a brain condition »Moving introduction by Joke Jaarsma in Ge… https://t.co/MeHVOAJPBq

    3 days ago

Keep in touch

Facebook Twitter Instagram
EAN Pages is a members service of the European Academy of Neurology https://www.ean.org

All content from January 2012 - June 2013 was published by EFNS; content from July 2013 - June 2014 by EFNS and ENS.

ISSN 2310-2934

Keep in touch

Facebook Twitter Instagram

Archives

Pages

  • Congress 2021
  • Privacy Policy
  • About us
  • Help
  • Contact

Back To Top